AstraZeneca: AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
Read full article »
CEO
Pascal Soriot
AstraZeneca is an England-based biopharmaceutical company that researches and develops prescription medicines for the treatment of cancer and renal diseases.
Read more